Keyphrases
Cyclin D1 (CCND1)
100%
Antisense Oligonucleotides
100%
Non-small Cell Lung Cancer Cells
100%
Mesothelioma Cells
100%
Cyclin-dependent Kinase 2 (CDK2)
28%
Induced Apoptosis
14%
Chemopreventive
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Therapeutic Target
14%
Cell Proliferation
14%
Cell-to-cell
14%
Protein Phosphorylation
14%
Potential Therapeutics
14%
Growth Inhibition
14%
Western Blot Analysis
14%
Cell Lysate
14%
Specificity Protein 1
14%
Immunoblotting
14%
Cellular Growth
14%
Phosphorylation State
14%
Cancer Types
14%
Proliferation Apoptosis
14%
Cyclin D1 Overexpression
14%
TUNEL Assay
14%
Multiple Cell Lines
14%
Phospho-antibodies
14%
Co-immunoprecipitation (co-IP)
14%
Medicine and Dentistry
Mesothelioma
100%
Non Small Cell Lung Cancer
100%
Cyclin D1
100%
Antisense Oligonucleotide
100%
Programmed Cell Death
28%
Cyclin-Dependent Kinase
28%
CD3 Antigen
28%
Malignant Neoplasm
14%
Cell Growth
14%
Cell Cycle
14%
Cell Proliferation
14%
Protein Phosphorylation
14%
Growth Inhibition
14%
Western Blot
14%
TUNEL Assay
14%
Immunoprecipitation
14%
Cell Line
14%
Immunoblotting
14%
Biochemistry, Genetics and Molecular Biology
Oligonucleotide
100%
Antisense
100%
Cyclin D1
100%
Cyclin-Dependent Kinase
28%
Programmed Cell Death
28%
Protein Phosphorylation
14%
Western Blot
14%
Cell Lysate
14%
Immunoprecipitation
14%
Cancer Cell
14%
Cell Cycle
14%
Cell Proliferation
14%
Cell Growth
14%
TUNEL Assay
14%
Growth Inhibition
14%
Immunoblotting
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Mesothelioma
100%
Cyclin D1
100%
Antisense Oligonucleotide
100%
Western Blot
28%
CD3 Antigen
28%
Immunoprecipitation
14%
Malignant Neoplasm
14%